Sonoma pharmaceuticals announces expanded partnership with global healthcare distributor for distribution of wound care products in canada

Boulder, co / accesswire / october 22, 2024 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced that it has entered into an amendment to its distribution agreement with a leading global healthcare distributor for the marketing and distribution of its wound care products in canada. as previously announced, on august 19, 2024, sonoma entered into a distribution agreement with a global healthcare distributor for the marketing and distribution of its wound care products in the united states, to be sold through hospital systems and other healthcare channels.
SNOA Ratings Summary
SNOA Quant Ranking